Journal Home
Search for

Volume 37, Issue 5, Pages 547-555 (July 2010)


View previous. 4 of 17 View next.

Microfluidic approach for fast labeling optimization and dose-on-demand implementation

Giancarlo PascaliaCorresponding Author Informationemail addressemail address, Grazia Mazzoneab, Giuseppe Saccomannic, Clementina Manerac, Piero A. Salvadoria

Received 8 January 2010; received in revised form 4 March 2010; accepted 16 March 2010. published online 26 April 2010.

Abstract 

Introduction

The diffusion of PET as a pivotal molecular imaging modality has emphasized the need for new positron-emitting radiotracers to be used in diagnostic applications and research. Microfluidic represents an innovative approach, owing to its potential to increase radiochemical productivity in terms of yields, time reduction, precursor consumption and flexible experimental planning.

Methods

We focused on fluorine-18 labeling and used a microfluidic platform to perform sequential reactions, by using the same batch of 18F-labeling solution on one or more substrates, during the same experimental session. A solid-phase extraction (SPE) workup procedure was also implemented in the system to provide a repeatable purification step.

Results

We were able to quickly optimize the conditions for labeling of ethyl and propyl ditosylate and of a new cannabinoid type 2 (CB2) receptor agonist, CB41. In all substrates, we obtained good incorporation yields (60% to 85%) in short (<90 s) reaction times. Single dosages of the CB2 ligand were sequentially prepared, upon request, in satisfactory quantities and purity for small animal PET scanning.

Conclusion

This work demonstrates the usefulness of a microfluidic-based system for a rapid optimization of temperature, flow rate of reactants and their relative ratio in the labeling of different precursors by using the same 18F-fluoride batch. This approach was used to obtain in sequence several injectable doses of a novel CB2 ligand, thus providing the proof of principle that microfluidic systems permit a dose-on-demand production of new radiotracers.

a Radiopharmacy Department, Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, Italy

b IUSS, Piazza Ghislieri, 27100 Pavia, Italy

c Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy

Corresponding Author InformationCorresponding author. Tel.: +39 050 3153519; fax: +39 050 3152063.

 This work was supported by the EU grant “ROC — Radiochemistry on Chip” and partly by an IFC-CNR Junior Grant 2009.

PII: S0969-8051(10)00063-6

doi:10.1016/j.nucmedbio.2010.03.006


View previous. 4 of 17 View next.